Press Releases HCC
Swiss News
Swiss Stocks Blog
Contact Us
Swiss Stocks Blog
Category Filter:

Aug
11
Novartis LCZ696 has a big potential in heart failure treatment: the company will present clinical data and highlight its effort in the field
Category: Pharmaceuticals
Posted On: 8/11/2014


Aug
2
UBS second quarter 2014 earnings release : Wealth Management franchise strength, but clients activity dip affects gross margin. Lack of visibility on litigation provision and on non-core legacy corporate center are headwinds. Ability to return cash to shareholders will be key.
Category: Banks
Posted On: 8/2/2014


Jul
22
Actelion published first half 2014 results above consensus even taken into account reversal of accruals for US rebate program (Tracleer) and lower tax rate due to recognition of loss carried forward in the US.
Category: Biotech
Posted On: 7/22/2014


Jul
16
Roche announces phase II clinical results of crenezumab in Alzheimer’s disease – comment on phase III progression yet
Category: Pharmaceuticals
Posted On: 7/16/2014


Jul
15
Roche to present data of phase II trial in a-beta program this week in Alzheimer’s disease
Category: Pharmaceuticals
Posted On: 7/15/2014


Jul
14
Lindt published strong sales development for the first half of 2014 and announced its biggest acquisition to date
Category: Consumer discretionary
Posted On: 7/14/2014


Jul
7
Helvetia Insurance to conduct a public tender offer for Nationale Suisse at CHF 80 per share
Category: Insurance
Posted On: 7/7/2014


Jul
7
Lafarge and Holcim announced list of asset disposals on the back of their planned merger agreement
Category: Industrials
Posted On: 7/7/2014


Jun
30
Actelion : Bank of America increase EPS on Selexipag news, game changer in PAH according to physicians’ feedback
Category: Biotech
Posted On: 6/30/2014


Jun
16
Sika continued step-up in EM, India plant opening
Category: Industrials
Posted On: 6/16/2014


Jun
13
Leonteq : More growth initiative announced
Category: Financial Service
Posted On: 6/13/2014


Jun
10
Burckhardt Compression FY 2013 : strong order intake and sales +20%, GM lower due to product mix and less service biz, EBIT and net income lower, but transition to faster long term growth
Category: Industrials
Posted On: 6/10/2014


Jun
2
Roche did not purchase Illumina (Nasdaq : ILMN) in 2012 but is making deals to be present in the different technologies that could play a big role in next generation DNA sequencing
Category: Pharmaceuticals
Posted On: 6/2/2014


May
29
Sonova management meeting
Category: Med Tech
Posted On: 5/29/2014


HCC is not responsible for, and expressly disclaims all liability for, damages of any kind arising out of use, reference to, or reliance on any information contained within the site. While the information contained within the site is periodically updated, no guarantee is given that the information provided in this website is correct, complete, and current. Although this website may include links providing direct access to other Internet resources, including websites, HCC is not responsible for the accuracy or content of information contained in these sites. Links from this website to third-party websites do not constitute an endorsement by HCC of the parties or their products and services. The appearance of advertisements and product or service information on this website or linked websites does not constitute an endorsement by HCC, and HCC has not investigated the claims made by any advertiser.